NCT03413982View on ClinicalTrials.gov

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

November 2, 2017

Primary Completion Date

January 1, 2030

Study Completion Date

January 1, 2035

Conditions

Bladder Cancer

Interventions

OTHER

Registry

Patient registry

Trial Locations (1)

66160

RECRUITING

University of Kansas Medical Center, Kansas City

All Listed Sponsors

lead

University of Kansas Medical Center

OTHER